DoW Autism Idea Development Award
Defense Health Agency Contracting Activity - DHACA
Free. Verify your email, then we send one reminder only.
- Posted
- May 21, 2026
- Amount
- $2,250,000
- Closes
- Oct 22, 2026 (in 90 days)
Classification and identifiers
- Solicitation number
- HT942526ARPIDA
- Assistance listing (CFDA)
- 12.420
Amount
$2,250,000
Who can apply
About this opportunity
Summary: The fiscal year 2026 (FY26) Autism Research Program (ARP) Idea Development Award supports the development of innovative, high-risk/high-reward research that could lead to critical discoveries or major advancements that will accelerate progress in improving outcomes for Autistic individuals. This award mechanism is designed to support innovative ideas with the potential to yield impactful data and new avenues of investigation. Distinctive Features: Applications are strongly encouraged to address one of the FY26 ARP Idea Development Award Areas of Interest or provide justification that the proposed research addresses a critical problem, question, or need in autism. Partnering Principal Investigator (PI) Option: The Partnering PI Option is structured so that two investigators, each o...
Related opportunities
- DoW Autism Career Development AwardDefense Health Agency Contracting Activity - DHACACloses in 90 days
- DoW Autism Clinical Trial AwardDefense Health Agency Contracting Activity - DHACACloses in 90 days
- DoW Epilepsy Idea Development AwardDefense Health Agency Contracting Activity - DHACACloses in 24 days
- DoW Multiple Sclerosis Exploration-Hypothesis Development AwardDefense Health Agency Contracting Activity - DHACACloses in 20 days
- DoW Prostate Cancer, Idea Development AwardDefense Health Agency Contracting Activity - DHACACloses in 40 days
- DoW Amyotrophic Lateral Sclerosis Research Program, Therapeutic Idea AwardDefense Health Agency Contracting Activity - DHACACloses in 68 days